Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study.

MLA

Toma, S., et al. “Efficacy of the Association of 13-Cis-Retinoic Acid (13cRA) and Alpha-Interferon 2a (Alpha-IFN 2a) in Moderate-Severe Cervical Intraepithelial Neoplasia (CIN II-III): A Pilot Study.” Anticancer Research, vol. 16, no. 2, Mar. 1996, pp. 931–36. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8687154&authtype=sso&custid=ns315887.

APA

Toma, S., Ragni, N., Raffo, P., Boselli, F., Gustavino, C., Rugiati, S., Formelli, F., Palumbo, R., Rosso, R., & De Cecco, L. (1996). Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study. Anticancer Research, 16(2), 931–936.

Chicago

Toma, S, N Ragni, P Raffo, F Boselli, C Gustavino, S Rugiati, F Formelli, R Palumbo, R Rosso, and L De Cecco. 1996. “Efficacy of the Association of 13-Cis-Retinoic Acid (13cRA) and Alpha-Interferon 2a (Alpha-IFN 2a) in Moderate-Severe Cervical Intraepithelial Neoplasia (CIN II-III): A Pilot Study.” Anticancer Research 16 (2): 931–36. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8687154&authtype=sso&custid=ns315887.